ZINCHLOR

This brand name is authorized in Nigeria

Active ingredients

The drug ZINCHLOR contains a combination of these active pharmaceutical ingredients (APIs):

1 Boric acid UNII R57ZHV85D4 - BORIC ACID
Boric Acid is a weakly acidic hydrate of boric oxide with mild antiseptic, antifungal, and antiviral properties. The exact mechanism of action of boric acid is unknown; generally cytotoxic to all cells. It is used in the treatment of yeast infections and cold sores. Read about Boric acid
2 Sodium chloride UNII 451W47IQ8X - SODIUM CHLORIDE
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. Read about Sodium chloride
3 Zinc sulfate UNII 89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM
Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children. Read about Zinc sulfate
4 Naphazoline UNII MZ1131787D - NAPHAZOLINE HYDROCHLORIDE
Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity. Read about Naphazoline
5 Chlorphenamine UNII V1Q0O9OJ9Z - CHLORPHENIRAMINE MALEATE
Chlorphenamine is a potent antihistamine (H₁-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H₁-receptor sites on tissues. Chlorphenamine also has anticholinergic activity. Read about Chlorphenamine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01GA51	Naphazoline, combinations	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GA Sympathomimetics used as decongestants
Discover more medicines within S01GA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NG	Registered Drug Product Database	Identifier(s): A4-9230

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.